期刊文献+

基于EV71交叉保护抗原P1的病毒样颗粒的构建

Construction of EV71 virus-like particles based on the cross protective antigen P1
原文传递
导出
摘要 目的构建基于EV71交叉保护抗原P1(CP1)的病毒样颗粒。方法利用昆虫杆状病毒表达系统构建CP1和3CD的重组杆状病毒,两者共同感染Sf9细胞,组装形成CP1的EV71病毒样颗粒,并通过Western blot和电镜进行鉴定。结果CP1、3CD重组杆状病毒共感染表达产物的Western blot结果显示,CP1蛋白经3CD蛋白酶酶切形成了大小约为39 k Da、34 k Da、26 k Da的VP1、VP0、VP3蛋白条带,电镜下可观察到形态规则的大小约为30 nm的CP1病毒样颗粒结构。结论CP1病毒样颗粒构建成功,为下一步探讨CP1病毒样颗粒是否对多种亚型的EV71病毒具有交叉保护作用奠定基础。 Objective To construct EV71 virus-like particles based on the cross protective antigen P1(CP1).Methods CP1 and 3 CD recombinant baculovirus was constructed by Bac-to-Bac baculovirus expression system.After co-infection to the Sf9 cells,the CP1 virus-like particles of EV71 was generated.Western blot and TEM were used for identification.Results Western blot showed three specific proteins bands whose molecular masses were corresponded to those of VP1(39 kDa),VP0(34 kDa)and VP3(26 kDa)were observed.TEM examination showed virus-like particles were observed.These particles measured about 30 nm in diameter,resembling the EV71 viral particles in size and appearance.Conclusion CP1 virus-like particles has been successfully constructed.It will lay a foundation for the immunoidentification to figure out whether CP1 virus-like particles could elicit immune responses neutralizing all EV71 genotypes and sub-genotypes virus.
作者 王昕 陈仕菊 彭博 武伟华 刘慧 房师松 WANG Xin;CHEN Shi-ju;PENG Bo;WU Wei-hua;LIU Hui;FANG Shi-song(Shenzhen Municipal Center for Disease Control and Prevention,Shenzhen,Guangdong 518055,China;不详)
出处 《中国卫生检验杂志》 CAS 2020年第14期1665-1667,共3页 Chinese Journal of Health Laboratory Technology
基金 国家自然科学基金(81871631) 深圳市科技计划项目(JCYJ20170306160244540) 深圳市卫生计生系统科研项目(201602002) 广东省医学科学技术研究基金项目(A2018269)。
关键词 肠道病毒71型 交叉保护抗原 病毒样颗粒 昆虫杆状病毒表达系统 Enterovirus 71 Cross protective antigens Virus-like particles Baculovirus expression system
  • 相关文献

参考文献4

二级参考文献28

  • 1Yao-Chi Chung,Jen-Huang Huang,Chia-Wei Lai,Heng-Chun Sheng,Shin-Ru Shih,Mei-Shang Ho,Yu-Chen Hu.Expression,purification and characterization of enterovirus-71 virus-like particles[J].World Journal of Gastroenterology,2006,12(6):921-927. 被引量:43
  • 2Zhang D, Lu J, Lu J. Enterovirus 71 vaccine: close but still far [J]. Int J Infect Dis, 2010, 14 (9): e739-e743.
  • 3Oberste MS,Maher K,Kilpatrick DR,et al.Molecular evolutionof the human enteroviruses : correlation of serotype with VP1sequence and application to picomavirus classification [J] JVirol, 1999,73(3) :1941-1948.
  • 4Shih SR,Ho MS,Lin KH,et al.Genetic analysis of enterovirus71 isolated from fatal and non-fatal cases of hand, foot andmouth disease during an epidemic in Taiwan, 1998 [J].VirusRes,2000,68(2) :127-136.
  • 5Brown BA,Oberste MS,Alexander JJ,et al.Molecular epid emiologyand evolution of enterovirus 71 strains isolated from 1970 to1998[J]. J Virol, 1999,73(12) :9969-9975.
  • 6Mcminn P,Lindsay K,Perera D,et al.Phylogenetic analysis ofenterovirus 71 strains isolated during linked epidemics inMalaysia, Singapore, and Western Australia [J].J Virol, 2001,75(16):7732-7738.
  • 7Giles BM,Ross TM.A computationally optimized broadly reactiveantigen (COBRA) based H5N1 VLP vaccine elicits broadlyreactive antibodies in mice and ferrets[J].Vaccine,2011,29( 16):3043-3054.
  • 8Kyte J,Doolittle RF. A simple method for displaying thehydropathic character of a protein[J].J Mol Biol, 1982,157(1):105-132.
  • 9Pa K. Prediction of chain flexibility in proteins[Z]. 1985.
  • 10Emini EA, Hughes JV, Perlow DS, et al.Induction of hepatitisA virus-neutralizing antibody by a virus-specific syntheticpeptide [J]. J Virol, 1985,55(3) : 836-839.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部